Editorial · 2016 · Open access

MCID — The Minimal Clinically Important Difference Assigns Significance to Outcome Effects

Felix Angst

The Journal of Rheumatology, 43(2), 258–259 · Published 1 February 2016 · DOI 10.3899/jrheum.151415

Open PDFView at the publisherCite this paper

In brief

“MCID — The Minimal Clinically Important Difference Assigns Significance to Outcome Effects” is an 2016 editorial by Felix Angst, published in The Journal of Rheumatology. OpenAlex counts 12 citations as of 22 November 2026. It is open access: the full text is free to read at The Journal of Rheumatology.

Citations
12
Most cited in
2018 (3)
References
12
Authors
1

Abstract

At medical school we were taught that 70–80% of the information that leads to diagnosis comes from the patient’s anamnesis. The severity of the subjective symptoms and disabilities drives the patient to seek medical help and has a major influence on treatment and intervention, despite “objective” findings such as alterations on a radiograph, for example, in a knee affected by osteoarthritis (OA)1. Based on this insight, a huge number of patient-rated outcome instruments have been developed in the past 2 decades2. Nevertheless, the significance of therapeutic effects is still quantified by statistical methods alone in many study reports, especially in pharmacological ones, even if the effects are labeled as “clinically significant”3. Beyond statistically and distribution-based quantification of effect significance, the dimension of an effect’s importance and significance, which includes the patient’s subjective perception of pain and function, reaches a higher sphere because it is closer to the central subject of interest in medicine, the patient. “It is recommended that the patient’s perspective be given the most weight, because these are patient-related outcome measures, although the clinician’s perspective is considered important as well”4. The founders of the concepts developed consequently to give this alternative meaning for outcome effects were Jaeschke and Redelmeier5,6. Jaeschke was the first investigator to ask patients to rate their subjectively perceived change of health or symptoms between baseline and followup5. The responses on this “transition” item were related to the score differences of an outcome instrument within the same time period … Address correspondence to Dr. F. Angst, RehaClinic, Quellenstr. 34, 5330 Bad Zurzach, Switzerland; E-mail: fangst{at}vtxmail.ch, f.angst{at}rehaclinic.ch

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Angst, F. (2016). MCID — The Minimal Clinically Important Difference Assigns Significance to Outcome Effects. The Journal of Rheumatology, 43(2), 258–259. https://doi.org/10.3899/jrheum.151415

MLA 9

Angst, Felix. “MCID — The Minimal Clinically Important Difference Assigns Significance to Outcome Effects.” The Journal of Rheumatology, vol. 43, no. 2, 2016, pp. 258–259. https://doi.org/10.3899/jrheum.151415.

Chicago

Angst, Felix. 2016. “MCID — The Minimal Clinically Important Difference Assigns Significance to Outcome Effects.” The Journal of Rheumatology 43 (2): 258–259. https://doi.org/10.3899/jrheum.151415.

Harvard

Angst, F. (2016) ‘MCID — The Minimal Clinically Important Difference Assigns Significance to Outcome Effects’, The Journal of Rheumatology, 43(2), pp. 258–259. doi:10.3899/jrheum.151415.

IEEE

F. Angst, “MCID — The Minimal Clinically Important Difference Assigns Significance to Outcome Effects,” The Journal of Rheumatology, vol. 43, no. 2, pp. 258–259, 2016, doi: 10.3899/jrheum.151415.

BibTeX

@article{angst2016mcid,
  title     = {{MCID — The Minimal Clinically Important Difference Assigns Significance to Outcome Effects}},
  author    = {Angst, Felix},
  journal   = {The Journal of Rheumatology},
  year      = {2016},
  volume    = {43},
  number    = {2},
  pages     = {258--259},
  doi       = {10.3899/jrheum.151415},
  url       = {https://doi.org/10.3899/jrheum.151415}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201611
201722
201833
202022
202311
202411
202511
202611

Topic and keywords

Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life

  • minimal clinically important difference
  • patient-rated outcome measures
  • patient perspectives
  • osteoarthritis
  • patient-reported outcomes

Work with this paper

Most-cited papers in Economics, Econometrics and Finance

All highly cited Economics, Econometrics and Finance papers

Questions about this paper

How do I cite this paper in APA style?

Angst, F. (2016). MCID — The Minimal Clinically Important Difference Assigns Significance to Outcome Effects. The Journal of Rheumatology, 43(2), 258–259. https://doi.org/10.3899/jrheum.151415

How many times has this paper been cited?

12 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at The Journal of Rheumatology: sign in and open the PDF from this page.

Who wrote this paper?

Felix Angst.

What is the DOI of this paper?

10.3899/jrheum.151415, permanently at https://doi.org/10.3899/jrheum.151415. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.